MedPath

University of Pavia

University of Pavia logo
🇮🇹Italy
Ownership
Private
Established
1361-01-01
Employees
1K
Market Cap
-
Website
http://www.unipv.it

Clinical Trials

113

Active:1
Completed:66

Trial Phases

4 Phases

Phase 2:1
Phase 3:5
Phase 4:9
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (80 trials with phase data)• Click on a phase to view related trials

Not Applicable
65 (81.3%)
Phase 4
9 (11.3%)
Phase 3
5 (6.3%)
Phase 2
1 (1.3%)

Biomimetic Hydroxyapatite Toothpaste and Mouthwash for Reducing Dental Sensitivity

Not Applicable
Not yet recruiting
Conditions
Tooth Sensitivity
Gingival Recession Generalized Moderate
Gingival Recession Localized Moderate
First Posted Date
2025-07-09
Last Posted Date
2025-07-09
Lead Sponsor
University of Pavia
Target Recruit Count
100
Registration Number
NCT07057141
Locations
🇮🇹

Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia, Pavia, Lombardy, Italy

Effectiveness of Coenzyme Q10 and Probiotics in Periodontal Therapy During Pregnancy

Not Applicable
Not yet recruiting
Conditions
Pregnancy
Periodontal Disease
Gingivitis
Dental Plaque
Probiotics
Coenzyme Q10
Microbiota
First Posted Date
2025-06-19
Last Posted Date
2025-06-26
Lead Sponsor
University of Pavia
Target Recruit Count
40
Registration Number
NCT07029360
Locations
🇮🇹

Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia, Pavia, Lombardy, Italy

Associations Apnoea Hypopnoea Index (AHI) and Malocclusions in Growing Patients With Maxillary Constriction

Not Applicable
Not yet recruiting
Conditions
Apnea, Obstructive Sleep
First Posted Date
2025-06-06
Last Posted Date
2025-06-11
Lead Sponsor
University of Pavia
Target Recruit Count
20
Registration Number
NCT07009535
Locations
🇮🇹

Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia, Pavia, Lombardy, Italy

Combined Use of Potassium Nitrate Gel and Diode Laser for Dentin Hypersensitivity

Not Applicable
Not yet recruiting
Conditions
Dentin Hypersensitivity
Interventions
Drug: Potassium Nitrate Gel
Device: Diode Laser (Active)
Device: Diode Laser (Sham)
First Posted Date
2025-05-13
Last Posted Date
2025-07-02
Lead Sponsor
University of Pavia
Target Recruit Count
23
Registration Number
NCT06967818
Locations
🇮🇹

Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia, Pavia, Lombardy, Italy

Associations Between Dental Anomalies and Ocular Diseases

Not yet recruiting
Conditions
Congenital Cataract
Tooth Abnormalities
Ocular Pathologies
First Posted Date
2025-04-30
Last Posted Date
2025-06-13
Lead Sponsor
University of Pavia
Target Recruit Count
5
Registration Number
NCT06950619
Locations
🇮🇹

Unit of Medical Genetics, Department of Molecular Medicine, University of Pavia, Pavia, Lombardy, Italy

🇮🇹

Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia, Pavia, Lombardy, Italy

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 23
  • Next

News

Solid Biosciences Receives FDA and Health Canada Approval for First-in-Class Gene Therapy Targeting Fatal Heart Rhythm Disorder

Solid Biosciences has received FDA IND and Health Canada CTA approval for SGT-501, a novel gene therapy designed to treat catecholaminergic polymorphic ventricular tachycardia (CPVT), a rare genetic heart condition that can cause sudden death.

China's BNCT Cancer Treatment Breakthrough: Neuboron Medical Group Reports Success with First Domestic System

Neuboron Medical Group has established China's first accelerator-based Boron Neutron Capture Therapy (BNCT) center, making China the second country globally to offer this advanced cancer treatment technology.

© Copyright 2025. All Rights Reserved by MedPath